Dimensional Fund Advisors LP Acumen Pharmaceuticals, Inc. Call Options Transaction History
Dimensional Fund Advisors LP
- $391 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding ABOS
# of Institutions
81Shares Held
38.2MCall Options Held
39.1KPut Options Held
53.4K-
Ra Capital Management, L.P. Boston, MA14.9MShares$21.2 Million0.34% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$4.85 Million1.6% of portfolio
-
Franklin Resources Inc San Mateo, CA3.14MShares$4.46 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$3.07 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.75 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $57.5M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...